92 related articles for article (PubMed ID: 6327591)
1. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. II. Isolation and structure determination.
Singh PD; Johnson JH
J Antibiot (Tokyo); 1984 Apr; 37(4):336-43. PubMed ID: 6327591
[TBL] [Abstract][Full Text] [Related]
2. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. I. Taxonomy, fermentation and biological properties.
Bush K; Henry PR; Slusarchyk DS
J Antibiot (Tokyo); 1984 Apr; 37(4):330-5. PubMed ID: 6327590
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of N-(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)glycyl-L-alanyl-D -isoglutamine analogues of muramyl dipeptide.
Calvo-Mateo A; De Las Heras FG
Carbohydr Res; 1986 Nov; 155():266-71. PubMed ID: 3791300
[No Abstract] [Full Text] [Related]
4. Synthesis of thiol-functionalized N-acetylmuramyl peptide congeners suitable for their conjugation to target molecules.
Moroder L; Gobbo M; Becker G; Wünsch E
Biol Chem Hoppe Seyler; 1989 Apr; 370(4):365-75. PubMed ID: 2757797
[TBL] [Abstract][Full Text] [Related]
5. Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP).
Hönig H; Zenk R
Chem Phys Lipids; 1990 Mar; 53(4):347-56. PubMed ID: 2340605
[TBL] [Abstract][Full Text] [Related]
6. Sleep-promoting effects of muramyl peptides.
Krueger JM; Pappenheimer JR; Karnovsky ML
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6102-6. PubMed ID: 6964403
[TBL] [Abstract][Full Text] [Related]
7. One-step purification procedure for UDP-N-acetylmuramyl-peptide murein precursors from Bacillus cereus.
Kohlrausch U; Höltje JV
FEMS Microbiol Lett; 1991 Mar; 62(2-3):253-7. PubMed ID: 1904044
[TBL] [Abstract][Full Text] [Related]
8. Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination.
Krueger JM; Karnovsky ML; Martin SA; Pappenheimer JR; Walter J; Biemann K
J Biol Chem; 1984 Oct; 259(20):12659-62. PubMed ID: 6490637
[TBL] [Abstract][Full Text] [Related]
9. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides.
Kotani S; Tsujimoto M; Koga T; Nagao S; Tanaka A; Kawata S
Fed Proc; 1986 Oct; 45(11):2534-40. PubMed ID: 3758371
[TBL] [Abstract][Full Text] [Related]
10. Synthetic muramyl peptides: their origin, present status, and future prospects. Introductory remarks.
Chedid L
Fed Proc; 1986 Oct; 45(11):2531-3. PubMed ID: 3758370
[No Abstract] [Full Text] [Related]
11. Muramyl peptides in mammalian tissues and their effects at the cellular level.
Karnovsky ML
Fed Proc; 1986 Oct; 45(11):2556-60. PubMed ID: 3758374
[TBL] [Abstract][Full Text] [Related]
12. Specific binding sites for muramyl peptides on murine macrophages.
Silverman DH; Krueger JM; Karnovsky ML
J Immunol; 1986 Mar; 136(6):2195-201. PubMed ID: 3950411
[TBL] [Abstract][Full Text] [Related]
13. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
14. New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines.
Lederer E
Drugs Exp Clin Res; 1986; 12(6-7):429-40. PubMed ID: 3527628
[TBL] [Abstract][Full Text] [Related]
15. Structure elucidation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus.
Hunt AH; Mynderse JS; Samlaska SK; Fukuda DS; Maciak GM; Kirst HA; Occolowitz JL; Swartzendruber JK; Jones ND
J Antibiot (Tokyo); 1988 Jun; 41(6):771-9. PubMed ID: 3403371
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
17. Phenacein--an angiotensin-converting enzyme inhibitor produced by a streptomycete. II. Isolation, structure determination and synthesis.
Liu WC; Parker WL; Brandt SS; Atwal KS; Ruby EP
J Antibiot (Tokyo); 1984 Nov; 37(11):1313-9. PubMed ID: 6096341
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and proinflammatory properties of muramyl tripeptides containing lysine and diaminopimelic acid moieties.
Roychowdhury A; Wolfert MA; Boons GJ
Chembiochem; 2005 Nov; 6(11):2088-97. PubMed ID: 16222728
[TBL] [Abstract][Full Text] [Related]
19. Physico-chemical properties of muroctasin.
Moroi R; Yamazaki K; Hirota T; Watanabe S; Kataoka K; Ichinose M
Arzneimittelforschung; 1988 Jul; 38(7A):953-9. PubMed ID: 3190802
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.
Ksander GM; Yuan AM; Diefenbacher CG; Stanton JL
J Med Chem; 1985 Nov; 28(11):1606-11. PubMed ID: 2999395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
